These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1452399)

  • 1. Anticomplementary activity of boswellic acids--an inhibitor of C3-convertase of the classical complement pathway.
    Kapil A; Moza N
    Int J Immunopharmacol; 1992 Oct; 14(7):1139-43. PubMed ID: 1452399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway.
    Kapil A; Sharma S
    J Pharm Pharmacol; 1994 Nov; 46(11):922-3. PubMed ID: 7897600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity.
    Englberger W; Hadding U; Etschenberg E; Graf E; Leyck S; Winkelmann J; Parnham MJ
    Int J Immunopharmacol; 1988; 10(6):729-37. PubMed ID: 3198307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
    Asghar SS; de Koster A; van der Helm HJ
    Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of rosmarinic acid on complement involves the C5 convertase.
    Peake PW; Pussell BA; Martyn P; Timmermans V; Charlesworth JA
    Int J Immunopharmacol; 1991; 13(7):853-7. PubMed ID: 1761351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of in vitro inhibition of activation of the classical and alternative pathways of human complement by the magnesium and sodium salts of the anti-inflammatory peptide N-acetyl-aspartyl-glutamic acid (NAAGA).
    Feuillard J; Maillet F; Goldschmidt P; Weiss L; Kazatchkine MD
    Agents Actions; 1991 Mar; 32(3-4):343-6. PubMed ID: 1862751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the immune system by Boswellia serrata extracts and boswellic acids.
    Ammon HP
    Phytomedicine; 2010 Sep; 17(11):862-7. PubMed ID: 20696559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.
    Ebanks RO; Isenman DE
    Mol Immunol; 1996 Feb; 33(3):297-309. PubMed ID: 8649451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopotentiating compounds from Tinospora cordifolia.
    Kapil A; Sharma S
    J Ethnopharmacol; 1997 Oct; 58(2):89-95. PubMed ID: 9406896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUT-175 as a potent inhibitor of C5/C3 convertase activity for production of C5a and C3a.
    Inagi R; Miyata T; Maeda K; Sugiyama S; Miyama A; Nakashima I
    Immunol Lett; 1991 Jan; 27(1):49-52. PubMed ID: 2019419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro anticomplementary activity of constituents from Morinda morindoides.
    Cimanga K; De Bruyne T; Lasure A; Van Poel B; Pieters L; Vanden Berghe D; Vlietinck A; Kambu K; Tona L
    J Nat Prod; 1995 Mar; 58(3):372-8. PubMed ID: 7775983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of C3 convertase in the rat classical complement pathway.
    Naito A; Okada H
    Microbiol Immunol; 1997; 41(8):621-4. PubMed ID: 9310942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis.
    Wildfeuer A; Neu IS; Safayhi H; Metzger G; Wehrmann M; Vogel U; Ammon HP
    Arzneimittelforschung; 1998 Jun; 48(6):668-74. PubMed ID: 9689425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer.
    Webster GF; McArthur WP
    Int Arch Allergy Appl Immunol; 1981; 66(3):304-9. PubMed ID: 6913544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of formation of complement C5-convertase].
    Kozlov LV; Lebedeva TV
    Bioorg Khim; 1998 May; 24(5):350-5. PubMed ID: 9661788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of the classical pathway of human complement by polymyxin B.
    Asghar SS; Boot T; van der Helm HJ
    Biochem Pharmacol; 1987 Sep; 36(18):2927-30. PubMed ID: 2820426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.